Hoth Therapeutics, Inc. (HOTH) |
| 0.8013 -0.018 (-2.22%) 08-05 15:59 |
| Open: | 0.82 |
| High: | 0.835 |
| Low: | 0.7911 |
| Volume: | 40,063 |
| Market Cap: | 11(M) |
| PE Ratio: | -1 |
| Exchange: | NASDAQ |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 2.35 |
| Resistance 1: | 1.74 |
| Pivot price: | 0.94 |
| Support 1: | 0.76 |
| Support 2: | 0.63 |
| 52w High: | 2.45 |
| 52w Low: | 0.4894 |
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Financials
| EPS | -0.800 |
| Book Value | 0.400 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -100.9 |
| Return on Equity (ttm) | -191.4 |
Company news
Thu, 01 Oct 2026
Hoth Therapeutics stock shifts toward drones after 100 percent deal - AD HOC NEWS
Sat, 30 May 2026
Rocket One Inc. Common Stock (RKTO) Stock Price, News & Analysis - MarketBeat
Fri, 29 May 2026
Rocket One (Nasdaq:RKTO) - Stock Analysis - Simply Wall Street
Thu, 28 May 2026
Rocket One Inc. Common Stock (RKTO) Historical Quotes - Nasdaq
Thu, 28 May 2026
Why Hoth Therapeutics (HOTH) Stock Is Surging After Hours Today - Benzinga
Thu, 28 May 2026
Hoth Therapeutics’ pivot to AI in space sees stock rocket after rebrand - Fierce Biotech
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
